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ABSTRACT
Objective: To examine the effect of different doses of triiodothyronine (T3) on mRNA levels of 
thyroid hormone receptors, TRα and TRβ, at different times. Materials and methods: 3T3-L1 
adipocytes were incubated with T3 (physiological dose: F; supraphysiological doses: SI or SII), 
or without T3 (control, C) for 0.5, 1, 6, or 24h. TRα and TRβ mRNA was detected using real-time 
polymerase chain reaction. Results: F increased TRβ mRNA levels at 0.5h. After 1h, TRα levels 
increased with F and SI and TRβ levels decreased with SII compared with C, F, and SI. After 6h, 
both genes were suppressed at all concentrations. In 24h, TRα and TRβ levels were similar to 
those of C group. Conclusions: T3 action with F began at 1h for TRα and at 0.5h for TRβ. These 
results suggest the importance of knowing the times and doses that activate T3 receptors in 
adipocytes. Arq Bras Endocrinol Metab. 2013;57(5):368-74
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RESUMO
Objetivo: Examinar o efeito de diferentes doses de triiodotironina (T3) sobre a expressão gêni-
ca dos receptores TRα e TRβ em diferentes tempos. Materiais e métodos: Adipócitos, 3T3-L1, 
foram incubados com T3 nas doses fisiológica (F, 10nM) e suprafisiológicas (SI, 100nM ou SII, 
1000nM) ou veículo (controle, C) durante 0,5, 1, 6 ou 24h. mRNA dos TRs foram detectados 
utilizando PCR em tempo real. Resultados: Níveis de TRβ aumentaram em F em 0,5h. Após 1h, 
níveis de TRα aumentaram em F e SI comparado ao C, enquanto TRβ diminuiu no SII compara-
do com C, F, e SI. Após 6h, ambos os genes foram suprimidos em todas concentrações. Em 24h, 
níveis de TRα e TRβ retornaram aos do C. Conclusões: Ação do T3 em F iniciou-se em 1h para 
TRα e 0,5h para TRβ. Esses resultados são importantes para determinar tempo inicial e dose de 
T3 em que os receptores de HT são ativados em adipócitos. Arq Bras Endocrinol Metab. 2013;57(5):368-74
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INTRODUCTION
T hyroid hormones (TH) influence the metabolism and development of adipose tissue by modulating 
the proliferation and differentiation of adipocytes (1). 
TH action is mediated mainly by the modification of 
gene expression by nuclear receptors, which are trans-
criptional factors regulated by ligands that adhere to 
the chromatin (2). TH receptors (TR) are proteins that 
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belong to the nuclear hormone receptor superfamily. 
These receptors originate from the genes for TR alpha 
(TRα) and TR beta (TRβ) (3,4) that, in humans, are 
located on chromosomes 17 and 3, respectively.
According to Yen (5) and Obregon (6), adipose tis-
sue represents an important target for TH because it 
expresses TRα and TRβ. THs are regarded as impor-
tant factors in the regulation of the development and 
function of adipose tissue (5,7,8). It has been shown 
that TRs are expressed in both white and brown adi-
pose tissue. However, there have been no studies on 
the modulation of TRs by different doses of triiodothy-
ronine (T3) at different times.
In this study, we evaluated the effects of different 
doses and times of T3 on the expression levels of TRs. 
We observed that TRβ was modulated by T3 starting 
at 0.5h, and TRα was modulated later, starting at 1h.
MATERIALS AND METHODS
Cell culture and differentiation
The experimental protocol was approved by the Ethics 
Committee on Animal Experiments of the Botucatu 
School of Medicine-UNESP (protocol nº 752).
For the in vitro study, the 3T3-L1 cell line was used. 
These cells were acquired from the Cell Bank of the Rio 
de Janeiro Federal University (UFRJ) and were cultu-
red in Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Gibco®, Life Technologies Corporation, Grand Island, 
NY, USA) was supplemented with 10% fetal bovine se-
rum (FBS) (Gibco®, Life Technologies Corporation), 
1% antibiotic/antimycotic (Sigma-Aldrich Co. LLC, 
St. Louis, MO, USA) agent, under an atmosphere of 
5% CO2 at 37°C. Cells were maintained in these cul-
ture conditions until they reached approximately 100% 
confluency, and were subsequently transferred to 6-well 
plates. After reaching 100% confluency in the wells, 
cells were submitted to the differentiation process, du-
ring which they remained for 3 days in DMEM contai-
ning 10% FBS, 100 mM 1-methyl-3-isobutilxanthine 
(IBMX) (Sigma-Aldrich Co. LLC), 1 mM dexame-
thasone (Sigma-Aldrich Co. LLC), and 5 mg/L insu-
lin (Sigma-Aldrich Co. LLC). After this period, cells 
were maintained for 7 days in DMEM containing 10% 
FBS and 5 mg/mL insulin. Following the period of 
cell differentiation, adipocytes were subjected to TH 
depletion for 36 h in DMEM supplemented with char-
coal-stripped fetal serum (Sigma-Aldrich Co. LLC). 
Subsequently, cells were treated with a physiological 
dose of T3 (10 nM, which is hereafter referred to as F) 
or supraphysiological doses of T3 (100 nM and 1000 
nM, which are hereafter called SI and SII, respectively) 
for 0.5, 1, 6, or 24h. A non-treated group, only 0.1% 
NaOH (diluent T3), was used as control (C).
Oil red O staining
After 10 days of differentiation, the culture medium 
was removed, and the cells were washed twice with 
phosphate-buffered saline. Subsequently, 1 mL of for-
maldehyde was added, and the cells were incubated for 
30 min at room temperature, and then washed 3 times 
with phosphate-buffered saline. Thereafter, 300 μL of 
Oil Red O dye (Sigma-Aldrich Co. LLC) was added, 
and the cells were incubated for 2h at 37°C. After that 
period, cells were washed 3 times with distilled water 
and placed in an incubator to dry. Cells were observed 
under a microscope in order to verify differentiation by 
red coloring of the adipose cells.
Gene expression
Total RNA was extracted from the 3T3-L1 cells with 
the TRIzol reagent (Life Technologies Corporation) 
according to the manufacturer’s instructions. The 
High Capacity cDNA Reverse Transcription Kit for 
RT-PCR® (Life Technologies Corporation) was used to 
synthesize 20 μL of cDNA from 1000 ng of total RNA.
TRα and TRβ mRNA levels (Table 1) were deter-
mined by real-time polymerase chain reactions (RT-qP-
CR). Quantitative measurements were performed with 
Applied Biosystems StepOne Plus detection system 
with the TaqMan qPCR commercial kit (Life Techno-
logies Corporation) according to the manufacturer’s 
instructions. The amplification conditions were as 
follows: enzyme activation at 50°C for 2 min, denatu-
ration at 95°C for 10 min. The cDNA products were 
amplified by 40 cycles of denaturation at 95°C for 15 s, 
and annealing/extension at 60°C for 1 min. All assays 
were performed in triplicate. Levels of gene expression 
Table 1. Assays used at RT-qPCR
Gene Assay
TRβ Mm00437044_m1
TRα Mm00617505_m1
Cyclophilin Mm00434759_m1
TRβ: thyroid hormone receptor beta; TRα: thyroid hormone receptor alpha. TRβ and TRα 
assays correspond to homologue sequence of isoforms 1 and 2. 
Co
py
rig
ht
©
 A
BE
&
M
 to
do
s o
s d
ire
ito
s r
es
er
va
do
s.
370 Arq Bras Endocrinol Metab. 2013;57/5
T3 modulation of TRα and TRβ
were quantified relative to group C value, after norma-
lization with the internal control (cyclophilin) by the 
2-ΔΔCt method, as described elsewhere (9).
Statistical analysis
The differences between TRα and TRβ mRNA le-
vels for all experiments were assessed by Student’s  t-
-test. Differences of TRα and TRβ gene expression for 
different T3 doses at each moment were assessed by 
one-way analyses of variance (ANOVA) followed by 
Tukey’s test. Data are expressed as mean ± standard de-
viation. Significance level was set at 5%.
RESULTS
Figure 1A shows 3T3-L1 cells prior to differentiation. 
In the presence of the differentiation cocktail (insulin, 
dexamethasone, and IBMX), cells differentiated from 
preadipocytes into adipocytes that had the morphology 
of mature adipocytes, characterized by a large quantity 
of lipid droplets in the cytoplasm (Figures 1B and C). 
These droplets become more evident with the oil red 
staining (Figure 1C), as the lipids get stained in red.
Differential expression of TRα and TRβ in adipocytes
Data obtained in the current study show differential 
expression of TRα and TRβ levels in adipocytes. TRα 
expression levels were higher in comparison with TRβ 
for all groups (Table 2).
Different concentrations of T3 modulated TRα mRNA 
levels at different time periods
Figure 2 shows the modulation of TRα mRNA levels 
in the 3T3-L1 adipocytes in the absence (C group) or 
presence of T3 (F, SI, and SII groups) at different mo-
Figure 1. 3T3-L1 cells. (A) Undifferentiated cells. (B) Cells after 10 days of differentiation. (C) Cells stained with oil red after 10 days of differentiation. 
The arrows indicate an adipocyte with lipid droplets in the cytoplasm.
A B C
Table 2. Differential expression of TRβ and TRα mRNA levels
  Group TRβ TRα p
0.5h 
C 1.00 ± 0.24 231.00 ± 68.22 < 0.001
F 2.63 ± 0.5 373.00 ± 75.52 = 0.001
SI 1.89 ± 0.24 323.59 ± 53.55 < 0.001
SII 1.88 ± 0.39 279.10 ± 54.80 < 0.001
1h 
C 1.00 ± 0.18 82.15 ± 7.01 < 0.001
F 1.10 ± 0.04 146.45 ± 17.29 < 0.001
SI 0.99 ± 0.11 176.11 ± 35.87 = 0.001
SII 0.42 ± 0.02 70.73 ± 10.40 < 0.001
6h 
C 1.00 ± 0.19 169.87 ± 17.79 < 0.001
F 0.22 ± 0.03 69.89 ± 7.98 = 0.001
SI 0.14 ± 0.003 34.93 ± 1.97 < 0.001
SII 0.04 ± 0.002 5.73 ± 0.31 < 0.001
24h 
C 1.00 ± 0.14 179.74 ± 44.72 = 0.002
F 0.76 ± 0.01 298.18 ± 12.69 < 0.001
SI 0.81 ± 0.04 201.82 ± 0.31 < 0.001
SII 0.79 ± 0.01 131.73 ± 17.4 < 0.001
3T3-L1 adipocytes were treated with T3 at physiological dose (F, 10 nM) and supraphysiological 
doses (SI, 100 nM or SII, 1000 nM) or without T3 (C, control) for 0.5h, 1h, 6h, or 24h. Total RNA 
was extracted and analyzed by RT-qPCR. Data are expressed as means ± standard deviations. 
Comparison between TRβ and TRα mRNA levels were analyzed using Student’s t test. All 
assays were performed in triplicate (n = 3 for each treatment). 
ments (0.5, 1, 6, or 24h), as measured by RT-qPCR. 
The different concentrations of T3 did not affect the 
levels of mRNA expression of the TRα gene in the 0.5-
h treatment period (Figure 2A). TRα expression levels 
were higher at 1h of treatment in the SI and F groups in 
comparison with the C and SII groups (Figure 2B). At 
the 6-h time point, TRα gene expression levels decrea-
sed in groups F, SI, and SII in comparison with group 
C (Figure 2C). TRα levels were increased in treatment 
group F at 24h compared with C. However, there was 
a decrease in the SI and SII groups in comparison with 
the increase that was observed in F (Figure 2D). 
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T3 modulation of TRα and TRβ
Figure 2. Dose-dependent response for the effects of T3 on TRα mRNA levels at different incubation times. The 3T3-L1 adipocytes were treated with T3 
at physiological dose (F, 10 nM) or supraphysiological doses (SI, 100 nM or SII, 1,000 nM), or without T3 (C, control) for 0.5h, 1h, 6h, or 24h. Total RNA 
was extracted and analyzed by RT-qPCR. (A) Effects of T3 doses on TRα mRNA levels at 0.5h. (B) Effects of T3 doses on TRα mRNA levels at 1h. (C) 
Effects of T3 doses on TRα mRNA levels at 6h. (D) Effects of T3 doses on TRα mRNA levels at 24h. Data are expressed as means ± standard deviations. 
Data were analyzed using one-way ANOVA complemented with Tukey’s test. Similar letters indicate that there was no statistical difference, and different 
letters indicate that there was a statistical deference at p < 0.05. Assays were performed in triplicate (n = 3 for each treatment).
Different concentrations of T3 modulated TRβ mRNA 
levels at different time periods
Figure 3 shows the modulation of TRβ mRNA levels 
in the 3T3-L1 adipocytes in the absence (C group) or 
presence of T3 (F, SI, and SII groups) at different pe-
riods (0.5, 1, 6, or 24h), as measured by RT-qPCR. 
There was an increase in TRβ mRNA levels in F group 
when compared with those of C, at 0.5h (Figure 3A). 
At 1h, suppression in the levels of TRβ gene expression 
was evident in SII compared with those of groups C, 
F, and SI (Figure 3B). At 6h, decrease in TRβ mRNA 
levels was observed in groups F, SI, and SII compared 
with those of group C (Figure 3C). At 24h, TRβ levels 
decreased in F group when compared with C (Figure 
3D).
DISCUSSION
Lipid metabolism is closely associated with a number 
of health problems; the regulation of adipocytes re-
presents an emerging area of interest. The adipose tis-
sue, which is a target of TH, shows the expression of 
thyroid receptors that are considered important factors 
in the regulation of the development and function of 
this tissue (5,7,8).
The present study was designed to elucidate the 
effects of T3 on TRα and TRβ mRNA expression levels 
in adipose tissue, without the interference of systemic 
factors. As experimental models, we used the 3T3-L1 
cell line, embryonic cells from Mus musculus (Figure 
1A), and differentiated in vitro adipocytes (Figures 1B 
and C) because they represent well-established mo-
dels for adipogenesis (10). Furthermore, we quantified 
TRα and TRβ mRNA levels by RT-qPCR.
The TRα gene is widely expressed in the early stages 
of development, while the TRβ gene is restricted to the 
late stages of embryogenesis when it is induced in the 
brain, pituitary gland, and other tissues (11). We ob-
served that TRα mRNA levels were much higher than 
TRβ mRNA levels in 3T3-L1 adipocytes (Table 2), in 
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Figure 3. Dose-dependent response for the effects of T3 on TRβ mRNA levels at different incubation times. The 3T3-L1 adipocytes were treated with T3 
at physiological dose (F, 10 nM) or supraphysiological doses (SI, 100 nM or SII, 1,000 nM), or without T3 (C, control) for 0.5h, 1h, 6h, or 24h. Total RNA 
was extracted and analyzed by RT-qPCR. (A) Effects of T3 doses on TRβ mRNA levels at 0.5h. (B) Effects of T3 doses on TRβ mRNA levels at 1h. (C) 
Effects of T3 doses on TRβ mRNA levels at 6h. (D) Effects of T3 doses on TRβ mRNA levels at 24h. Data are expressed as means ± standard deviations. 
Data were analyzed using one-way ANOVA complemented with Tukey’s test. Similar letters indicate that there was no statistical difference, and different 
letters indicate that there was a statistical deference of p < 0.05. Assays were performed in triplicate (n = 3 for each treatment).
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agreement with other authors (12). The differential ex-
pression of TR genes suggests that they may mediate 
distinct functions (13). It has been shown that TRα1 
is critical in thermoregulation via regulation at the level 
of local, via central regulation, or both, whereas TRβ 
seems to be more involved in the regulation of lipid 
metabolic pathways (14). Moreover, although TRα 
and TRβ are similar in the DNA and ligand domains 
(15), there are fundamental differences in the ligand-
binding domain that, nowadays, have enabled the de-
sign of ligands that specifically interact with TRα or 
TRβ, and these have been important tools of isoform-
specific actions (16). 
We observed that the modulation of the levels of 
TRα by different doses of T3 was initiated after 1h of 
treatment when the physiological dose of 10 nM (17) 
that was given to group F increased the levels of TRα 
compared with those of groups C and SI. The TRα 
expression levels in the SII group remained unchanged 
compared with group C (Figure 2A). We can speculate 
that this consistency in the TRα expression levels in the 
SII group was due to a downregulation of this recep-
tor because this group showed a decrease in TRα levels 
compared with groups F and SI. The downregulation 
process occurred due to the exposure of the cells to 
high doses of TH (18). 
Monden and cols. (19) observed a decrease in TRα 
mRNA levels in human medulloblastoma cells (HTB-
185) at a dose of 100 nM, which was the same dose 
used in the SI group for 24h. In the present study, we 
also observed a reduction in TRα in this group com-
pared with the T3 physiological levels that were admi-
nistrated to group F. However, group F had increased 
TRα levels compared with group C, and group SII was 
decreased relative to F (Figure 2D).
Kanamori e Brown (20) showed that T3 modulated 
the TRα mRNA expression levels in tadpoles, but it 
had no effect on the epithelial cell culture of embryonic 
Xenopus laevis (XL-177) incubated with T3 for 24h at 
a concentration of 5 nM. These findings do not cor-
T3 modulation of TRα and TRβ
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roborate our results, which may be due to the use of a 
different experimental model and of a T3 dose that was 
lower than that used in our experiments.
Jiang and cols. (12) analyzed the TRα expression 
levels during the differentiation period of 3T3-L1 cells 
in the absence or presence of T3 at a concentration of 
100 nM. Although the treated group had a higher ac-
cumulation of triglycerides, the TRα expression levels 
were similar for both treated and untreated cells, di-
fferent from our results, and probably because mRNA 
quantification by semi-quantitative PCR is less sensitive 
than that done with RT-qPCR.
We observed an increase in TRβ mRNA levels in 
group F after 0.5-h incubation, but not for TRα (Figu-
re 3A). This led us to speculate that at 0.5h, T3 bound 
to its receptor α, which is more abundant in adipocytes, 
resulting in an increased transcription of TRβ. After the 
1-h incubation, we observed a decrease in TRβ levels 
in group SII relative to the other groups (Figure 3B), 
which indicated a decrease of thyroid receptors in the 
presence of high doses of T3.
Increasing the incubation period to 6h, we obser-
ved a suppression of TRβ in the F, SI, and SII groups 
compared with those in the C group, which was the 
same observed for TRα (Figures 3C and 2C). If the 
transcription of TRβ depends on the binding of T3 to 
TRα, that would explain the decreased levels of TRβ at 
this incubation time.
At 24h, only the F group maintained TRβ levels 
below group C (Figure 3D). There was an increase in 
the expression of TRβ at 0.5h, which was followed by 
a progressive reduction until 6h; TRβ levels tended to 
return to normality in 24h. This suggested that a de-
fense or adaptation mechanism occurred in the cells in 
response to treatment with TH.
Previous studies from our group have shown that 
physiological doses of T3 decreased TRβ gene expres-
sion levels in the adipose tissue of obese animals that 
were subjected to food restriction (21), corroborating 
the results obtained in the present study at 6 and 24h. 
Moreover, Liu and cols. (22) found that TRβ gene ex-
pression levels remain unchanged in the myocardium 
of hyperthyroid rats compared with the myocardium of 
euthyroid rats, suggesting that the actions of T3 in its 
receptors are different for different tissues and experi-
mental models.
In summary, the physiological and supraphysiologi-
cal doses of T3 modulated TR mRNA expression levels 
by showing that, at 6h, a suppression of both genes 
occurred in the presence of different doses of T3, and 
that, after 24h, the expression levels tended to return 
to normality. Since the interaction with the T3 nuclear 
receptors leads to the activation or inhibition of target 
expression of genes, implying the stimulation or blo-
cking of the synthesis of specific proteins, mechanism 
by which TH exerts its biological effects on cells, the 
results presented are important for an understanding in 
which T3 dose (physiological or supraphysiological), at 
different incubation times, T3 activates thyroid hormo-
ne receptors in adipocytes.
Acknowledgements: we are grateful to Sueli A. Clara, José C. 
Georgete, Mário B. Bruno, and Keize Nagamati Junior for their 
technical support. We also would like to thank Editage for the 
translation of the manuscript into English. Capes and Fapesp 
(# 2010/16911-4) provided us with financial support.
Disclosure: no potential conflict of interest relevant to this article 
was reported. 
REFERENCES
1. Darimont C, Gaillard D, Ailhaud G, Negrel R. Terminal differentia-
tion of mouse preadipocyte cells: adipogenic and antimitogenic 
role of triiodothyronine. Mol Cell Endocrinol. 1993;98(1):67-73. 
2. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid 
hormone actions. Endocrin Rev. 2010;31(2):139-70. 
3. Williams GR. Cloning and characterization of two novel thyroid hor-
mone receptor beta isoforms. Mol Cell Biol. 2000;20(22):8329-42. 
4. Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande 
O, et al. Increased sensitivity to thyroid hormone in mice with 
complete deficiency of thyroid hormone receptor alpha. Proc Natl 
Acad Sci USA. 2001;98(1):349-54. 
5. Yen PM. Physiological and molecular basis of thyroid hormone 
action. Physiol Rev. 2001;81(3):1097-142. 
6. Obregon MJ. Thyroid hormone and adipocyte differentiation. 
Thyroid. 2008;18(2):185-95.
7. Flores-Delgado G, Marsch-Moreno M, Kuri-Harcuch W. Thyroid 
hormone stimulates adipocyte differentiation of 3T3 cells. Mol 
Cell Biochem. 1987;76(1):35-43. 
8. Chawla A, Lazar MA. Induction of Rev-ErbA alpha, an orphan 
receptor encoded on the opposite strand of the alpha-thyroid 
hormone receptor gene, during adipocyte differentiation. J Biol 
Chem. 1993;268(22):16265-9. 
9. Livak KJ, Schmittgen TD. Analysis of relative gene expression 
data using real-time quantitative PCR and the 2(-Delta Delta C(T)) 
Method. Methods. 2001;25(4):402-8. 
10. Green H, Meuth M. An established pre-adipose cell line and its 
differentiation in culture. Cell. 1974;3(2):127-33. 
11. Bradley DJ, Towle HC, Young WS, 3rd. Spatial and temporal ex-
pression of alpha- and beta-thyroid hormone receptor mRNAs, 
including the beta 2-subtype, in the developing mammalian ner-
vous system. J Neurosci. 1992;12(6):2288-302. 
12. Jiang W, Miyamoto T, Kakizawa T, Sakuma T, Nishio S, Takeda 
T, et al. Expression of thyroid hormone receptor alpha in 3T3-
L1 adipocytes; triiodothyronine increases the expression of 
lipogenic enzyme and triglyceride accumulation. J Endocrinol. 
2004;182(2):295-302. 
T3 modulation of TRα and TRβ
Co
py
rig
ht
©
 A
BE
&
M
 to
do
s o
s d
ire
ito
s r
es
er
va
do
s.
374 Arq Bras Endocrinol Metab. 2013;57/5
13. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner 
JM, et al. Recessive resistance to thyroid hormone in mice lack-
ing thyroid hormone receptor beta: evidence for tissue-specific 
modulation of receptor function. EMBO J. 1996;15(12):3006-15. 
14. Zhu X, Cheng SY. New insights into regulation of lipid metabo-
lism by thyroid hormone. Curr Opin Endocrinol Diabetes Obes. 
2010;17(5):408-13. 
15. Liu YY, Schultz JJ, Brent GA. A thyroid hormone receptor alpha 
gene mutation (P398H) is associated with visceral adiposity 
and impaired catecholamine-stimulated lipolysis in mice. J Biol 
Chem. 2003;278(40):38913-20. 
16. Figueira AC, Saidemberg DM, Souza PC, Martinez L, Scanlan TS, 
Baxter JD, et al. Analysis of agonist and antagonist effects on 
thyroid hormone receptor conformation by hydrogen/deuterium 
exchange. Mol Endocrinol. 2011;25(1):15-31. 
17. Yoshida T, Monkawa T, Hayashi M, Saruta T. Regulation of ex-
pression of leptin mRNA and secretion of leptin by thyroid 
hormone in 3T3-L1 adipocytes. Biochem Biophys Res Comm. 
1997;232(3):822-6.
18. Franklyn JA, Ramsden DB, Sheppard MC. Down-regulation of 
nuclear T3 receptors by thyroid hormones in the rat anterior pitu-
itary. Mol Cell Endocrinol. 1985;40(2-3):145-8.
19. Monden T, Nakajima Y, Hashida T, Ishii S, Tomaru T, Shibusawa N, 
et al. Expression of thyroid hormone receptor isoforms down-
regulated by thyroid hormone in human medulloblastoma cells. 
Endocr J. 2006;53(2):181-7. 
20. Kanamori A, Brown DD. The regulation of thyroid hormone re-
ceptor beta genes by thyroid hormone in Xenopus laevis. J Biol 
Chem. 1992; 267(2):739-45. 
21. Luvizotto RA, Conde SJ, Sibio MT, Nascimento AF, Lima-Leopol-
do AP, Leopoldo AS, et al. Administration of physiologic levels 
of triiodothyronine increases leptin expression in calorie-restrict-
ed obese rats, but does not influence weight loss. Metabolism. 
2010;59(1):1-6. 
22. Liu CR, Li LY, Shi F, Zang XY, Liu YM, Sun Y, et al. Effects of hy-
per- and hypothyroid on expression of thyroid hormone receptor 
mRNA in rat myocardium. J Endocrinol. 2007;195(3):429-38.
T3 modulation of TRα and TRβ
